共 276 条
[51]
Liu Y(2013)microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin Oncol Lett 6 621-2953
[52]
Zhu M(2019)Effects of microRNA-1271 on ovarian cancer via inhibition of epithelial-mesenchymal transition and cisplatin resistance J Obstet Gynaecol Res 45 196-141
[53]
Yang L(2015)MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1 Oncotarget 6 3817-101
[54]
Wang X(2020)miR-548e sponged by ZFAS1 regulates metastasis and Cisplatin resistance of OC by targeting CXCR4 and let-7a/BCL-XL/S signaling Axis Mol Ther Nucleic Acids 20 1410-4954
[55]
Sun C(2015)miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway Mol Cancer 14 1003-580
[56]
Zhao H(2021)LNC00115 mediates Cisplatin resistance by regulating the miR-7/ERK Signalling pathway in ovarian cancer Cancer Manag Res 13 12369-332
[57]
Guo H(2018)miR-378a-3p sensitizes ovarian cancer cells to cisplatin through targeting MAPK1/GRB2 Biomed Pharmacother 107 1146-461
[58]
Guo P(2014)Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma Oncol Rep 32 190-3644
[59]
Wu D(2014)MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells Tumour Biol 35 2940-12626
[60]
Qin X(2019)MiR-338-3p enhances ovarian cancer cell sensitivity to Cisplatin by Downregulating WNT2B Yonsei Med J 60 616220-C235